Arvinas Alternatives & Competitors
12 companies similar to Arvinas — Leading the way in targeted protein degradation therapeutics
Companies similar to Arvinas
Avilar Therapeutics
Pioneering the discovery and development of extracellular protein degraders.
Precigen
Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of ge...
Captor Therapeutics SA
Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the diffic...
Rival Readout
Competing with Arvinas? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Orum Therapeutics
A public biotechnology company pioneering a novel class of protein degraders.
Relay Therapeutics
Integrating leading-edge computational and experimental science to transform human health....
Forma Therapeutics
Dedicated to transforming the lives of patients with rare hematologic diseases and cancers...
Cullgen Inc.
Powering protein degradation for tomorrow's medicines
Lisata Therapeutics, Inc.
Targeted Therapy Delivered
HAVAH Therapeutics
Developing prevention and early treatment options for hormonally driven breast cancer and...
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly select...
Wren Therapeutics
Stopping the wave of neurodegeneration at its source
About Arvinas
Arvinas is a clinical-stage biopharmaceutical company founded in 2013 and headquartered in the United States. The company is committed to developing targeted protein degradation therapeutics with the aim of improving the lives of patients suffering from debilitating and life-threatening diseases. Their proprietary PROT...
Biopharmaceutical, Protein Degradation, Therapeutics, Clinical-stage, Disease Treatment, PROTAC® Discovery Engine Platform, Proteolysis Targeting Chimeras, Metastatic Castrate-resistant Prostate Cancer, Locally Advanced Breast Cancer, Metastatic ER+/HER2- Breast Cancer, Drug Discovery, Autoimmune Diseases, Rare Diseases, Cancer Therapy, Preclinical Pipeline
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Arvinas: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Arvinas on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.